Coral Tooth

University R&D

Bioactives
nerve health research

Coral Tooth works with university research groups in Germany and Switzerland to deepen understanding of Hericium coralloides bioactives — from metabolite profiling and batch-to-batch marker standardisation to preclinical models of nervous-system signalling. The goal is science-led B2B ingredient positioning, not commodity mushroom marketing.

Bioactive metabolite profiling

Identification and quantification of corallocins, hericenes, β-glucans, and related terpenoid and polysaccharide fractions across harvest stage, tissue type, and processing lane — building the analytical basis for partner COAs and release specs.

Standardisation & assay development

Collaborative work on species-specific marker assays so B2B buyers receive reproducible specifications — moving beyond vague “polysaccharide” totals toward coralloides-relevant chemistry.

Nervous-system signalling — preclinical models

University-led in vitro and ex vivo research into neurotrophic pathways associated with Hericium extracts — including NGF/BDNF-related readouts linked to corallocin literature — under strict preclinical framing without disease or clinical outcome claims.

Extraction & delivery science

Comparative evaluation of hydrosoluble versus lipophilic fractions, and how lipid carriers (liposomes, glycerosomes, phytosomes) interact with terpenoid-rich streams — informing the branched processing architecture for partner formulations.

Our academic partners contribute independent analytical rigour, peer-review culture, and access to advanced instrumentation — while we supply characterised fruiting-body material, cultivation traceability, and format-specific samples from the Jasło platform. Findings feed directly into partner documentation, R&D narratives, and future species-specific evidence — always species-labelled as Hericium coralloides, never borrowed from lion’s mane trials.

GermanySwitzerland

University collaborations support preclinical R&D and ingredient characterisation only. They do not constitute human clinical proof for finished supplement claims. EU food-supplement copy must remain within permitted health-claim and species-evidence boundaries.

For the full species profile, corallocin literature, and ingredient specifications, see Hericium coralloides.

Explore Coral Tooth